<SEC-DOCUMENT>0001104659-25-058641.txt : 20250612
<SEC-HEADER>0001104659-25-058641.hdr.sgml : 20250612
<ACCEPTANCE-DATETIME>20250611202040
ACCESSION NUMBER:		0001104659-25-058641
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250611
FILED AS OF DATE:		20250612
DATE AS OF CHANGE:		20250611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Grifols SA
		CENTRAL INDEX KEY:			0001438569
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35193
		FILM NUMBER:		251041411

	BUSINESS ADDRESS:	
		STREET 1:		1585 BROADWAY
		STREET 2:		SUITE 2376
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-969-3335

	MAIL ADDRESS:	
		STREET 1:		1585 BROADWAY
		STREET 2:		SUITE 2376
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2517815d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 <BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of June&nbsp;2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File No.&nbsp;001-35193</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grifols, S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Avinguda de la Generalitat, 152-158</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Parc de Negocis Can Sant Joan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sant Cugat del Valles 08174</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Barcelona, Spain</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of registrant&rsquo;s principal executive
office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form&nbsp;20-F <FONT STYLE="font-family: Wingdings">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F
<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grifols, S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Item</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Sequential&nbsp;Page&nbsp;Number</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: left; width: 10%"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">1.</FONT></A></TD>
    <TD STYLE="text-align: left"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">Other Relevant Information, dated June 11, 2025</FONT></A></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 15%"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 70%"><IMG SRC="tm2517815d1_6kimg001.jpg" ALT=""></TD>
  <TD STYLE="width: 30%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><A NAME="a_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grifols,
S.A.<BR>
<BR>
</B></FONT>Avinguda de la Generalitat 152-158<BR>
 08174 Sant Cugat del Vall&egrave;s<BR>
 Barcelona - SPAIN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Tel. [34] 935 710 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Fax [34] 935 710 267</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><U>www.grifols.com</U></P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Pursuant to the provisions of Article
227 of Law 6/2023 of March 17, on Securities Markets and Investment Services, Grifols, S.A., Barcelona, Spain (&quot;<B>Grifols</B>&quot;
or the &quot;<B>Company&quot;</B>) hereby informs about the following</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OTHER RELEVANT INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.4pt 0pt 5.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As a continuation of the Privileged
Information notes filed by Grifols on March 31, 2025 and May 6, 2025 of this year in relation to the public delisting purchase offer launched
by its subsidiary Grifols Biotest Holdings GmbH, Frankfurt am Main, Germany to all shareholders of Biotest Aktiengesellschaft, Dreieich,
Germany (&quot;<B>Biotest</B>&quot;) to acquire all ordinary shares of Biotest at a price of &euro;43.00 per ordinary share and all non-voting
preferred shares of Biotest at a price of &euro;30.00 per non-voting preferred share (the &quot;<B>Delisting Offer</B>&quot;), in accordance
with the Offer Document the acceptance period ended on June 6, 2025 at 24:00 hours (local time in Frankfurt am Main) / 18:00 hours (local
time in New York).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.5pt 0pt 5.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Delisting Offer has been accepted
for a total of 416,922 ordinary shares of Biotest and a total of 3,002,804 non-voting preferred shares of Biotest. Regarding the ordinary
shares, this corresponds to a stake of approximately 2.11% of all issued voting ordinary shares and approximately 1.05% of Biotest's share
capital. Regarding the non-voting preferred shares, this corresponds to a stake of approximately 15.18% of all issued non-voting preferred
shares of Biotest, as well as approximately 7.59% of Biotest's share capital. In this regard, Grifols will pay a total of &euro; 108,011,766
as the offer price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.4pt 0pt 5.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As a result of the Delisting Offer,
Grifols will hold, directly and indirectly through its subsidiary Grifols Biotest Holdings GmbH, 99.25% of all issued voting ordinary
shares and 61.40% of all issued non-voting preferred shares of Biotest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.7pt 0pt 5.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As described in more detail in Section
12.5 of the Offer Document, the settlement of the Delisting Offer and the payment of the corresponding Offer Price for the Biotest shares
submitted for sale will be made no later than the fourth business day following this communication, in accordance with the terms and conditions
of the Offer Document. The settlement of the Delisting Offer is expected to take place on June 16, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.5pt 0pt 5.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Furthermore, it is also reported
that Biotest has received the formal notification of the approval of the application for the revocation of the admission of its shares
to trading by the Frankfurt Stock Exchange. The delisting is effective as of June 6, 2025. As from that date, Biotest shares are no longer
traded on the Frankfurt Stock Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In Barcelona, June 11, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Nuria Mart&iacute;n Barn&eacute;s</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Secretary of the Board of Directors</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SIGNATURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Grifols,&nbsp;S.A.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ David I. Bell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 42%"><FONT STYLE="font-size: 10pt">David I. Bell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Authorized Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&nbsp; June 11, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2517815d1_6kimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2517815d1_6kimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U /H# 2(  A$! Q$!_\0
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MYFE5J5.Z*'P)_P"1^F_Z\G_F*^@M>_Y%W4_^O27_ - -?/OP)_Y'Z;_KR?\
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II0OL>F>%O V@^#X6&EVN)W&'N)3ND;\>P]ABNCHHKGE)R=V:)):(_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
